|
ZFP37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.80260000004484E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.15579999998761E-06 |
| Normal-vs-Stage2 |
4.971000E-04 |
| Normal-vs-Stage3 |
7.551700E-04 |
| Normal-vs-Stage4 |
3.599600E-03 |
| Stage1-vs-Stage2 |
8.629200E-01 |
| Stage1-vs-Stage3 |
7.491400E-01 |
| Stage1-vs-Stage4 |
6.301200E-01 |
| Stage2-vs-Stage3 |
6.889800E-01 |
| Stage2-vs-Stage4 |
7.579200E-01 |
| Stage3-vs-Stage4 |
5.375800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.826500000365E-07 |
| Normal-vs-AfricanAmerican |
1.378570E-03 |
| Normal-vs-Asian |
1.061480E-03 |
| Caucasian-vs-AfricanAmerican |
1.833160E-01 |
| Caucasian-vs-Asian |
2.550400E-01 |
| AfricanAmerican-vs-Asian |
1.306220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.86840000032862E-08 |
| Normal-vs-Female |
7.541200E-03 |
| Male-vs-Female |
4.852200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.095790E-03 |
| Normal-vs-Extreme_Weight |
8.24960000311847E-08 |
| Normal-vs-Obese |
4.065000E-03 |
| Normal-vs-Extreme_Obese |
7.806500E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.143400E-01 |
| Normal_Weight-vs-Obese |
5.190600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.942800E-01 |
| Extreme_Weight-vs-Obese |
4.936400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.644200E-01 |
| Obese-vs-Extreme_Obese |
2.090200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.86839999999755E-05 |
| Normal-vs-Age(41-60Yrs) |
9.351600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.51860000019433E-07 |
| Normal-vs-Age(81-100Yrs) |
2.622000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.091800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.736200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.082600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.226400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.704600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.648000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.4759999999977E-05 |
| Normal-VS-Type2 PRCC |
5.6622999622391E-09 |
| Normal-VS-KIRP CIMP |
1.973480E-04 |
| Normal-VS-Unclassified PRCC |
3.877800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.079700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.077160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.213200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.861800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.781600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.337050E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.40030000320246E-08 |
| Normal-vs-N1 |
2.260900E-03 |
| Normal-vs-N2 |
4.080200E-03 |
| N0-vs-N1 |
1.650410E-01 |
| N0-vs-N2 |
3.934400E-01 |
| N1-vs-N2 |
2.858800E-01 |
|
|
